The mission of “European Biopharmaceutical Enterprises” (EBE) is to:
Represent biopharmaceutical companies of all sizes operating in Europe in the formulation of policies at global and European levels.
Support innovation initiatives and new opportunities for biopharmaceutical technologies in the European knowledge-based economy.
Contribute industry expertise to the development of new regulatory frameworks, guidelines and standards of relevance to biopharmaceuticals.
Promote the exchange of good practices to foster the development of safe, efficacious and high-quality medicines.
Increase awareness of the sector, its products and the tangible benefits that biopharmaceuticals bring to patients and society worldwide.
Support the business development of member companies, especially SMEs, through advice, networking, training and educational opportunities.
Facilitate information exchange and communications between all stakeholders within the field of biopharmaceuticals through EBE acting as resource centre.